CALCIUM OVERLOAD AND APOPTOSIS IN VASCULAR TOXICITY
CALCIUM OVERLOAD AND APOPTOSIS IN VASCULAR TOXICITY
批准号:
2520437
负责人:
Daniel Joseph Conklin
金额:
$1.17万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
未结题
起止时间:
1998-08-01 至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Toxicant-induced cardiovascular disease is an important and useful model
for studying pathological and toxicological mechanisms. The goal of
this proposal is to define toxicological mechanisms of action for the
cardiovascular-specific toxicant allylamine, using well developed and
previously described in vivo toxicant-induced models of vascular
pathology. The synthetic primary amine allylamine rat model is used to
study toxicological mechanisms involved in myocardial necrosis,
atherosclerosis and vascular smooth muscle cell death. The role of
calcium overload in allylamine-induced myocardial necrosis and
atherosclerotic-like lesions will be assessed by administration of
stereoisomers of the calcium channel blocker verapamil, and
quantification of cardiovascular lesions, aortic physiology and aortic
myosin heavy chain isoforms. The aortic medial vascular smooth muscle
toxicity resulting from biochemical manipulation of allylamine
intoxication (i.e., combination with beta-aminopropionitrile, phenelzine
or hydralazine) will be characterized as either apoptosis or cellular
necrosis. Apoptosis will be quantified via aortic in situ terminal
deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)
staining and aortic DNA fragmentation by gel electrophoresis and enzyme-
linked immunoassay (ELISA). These studies will aid in understanding the
mechanisms of xenobiotic amine toxicity and the pathogenesis of
cardiovascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cardiovascular Benefits of Inhaled Biogenic Volatile Organic Compounds
-
批准号:10459548
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2021
-
负责人:Daniel Joseph Conklin
-
依托单位:
Cardiovascular Benefits of Inhaled Biogenic Volatile Organic Compounds
-
批准号:10288039
-
项目类别:
-
资助金额:$23.41万
-
财政年份:2021
-
负责人:Daniel Joseph Conklin
-
依托单位:
Animal Models and Phenotyping Core
-
批准号:10208902
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2018
-
负责人:Daniel Joseph Conklin
-
依托单位:
Animal Models and Phenotyping Core
-
批准号:10452736
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2018
-
负责人:Daniel Joseph Conklin
-
依托单位:
Novel Treatments of Acrolein-induced Cardiotoxicity
-
批准号:8610016
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2013
-
负责人:Daniel Joseph Conklin
-
依托单位:
Core B: Tobacco Product Evaluation and Exposure Core
-
批准号:8595396
-
项目类别:
-
资助金额:$74.85万
-
财政年份:2013
-
负责人:Daniel Joseph Conklin
-
依托单位:
Novel Treatments of Acrolein-induced Cardiotoxicity
-
批准号:8740481
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2013
-
负责人:Daniel Joseph Conklin
-
依托单位:
Cardioprotective Mechanisms of Glutathione S-transferase P
-
批准号:7838943
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2009
-
负责人:Daniel Joseph Conklin
-
依托单位:
Cardioprotective Mechanisms of Glutathione S-transferase P
-
批准号:8212058
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2008
-
负责人:Daniel Joseph Conklin
-
依托单位:
Cardioprotective Mechanisms of Glutathione S-transferase P
-
批准号:7466262
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2008
-
负责人:Daniel Joseph Conklin
-
依托单位:
Cardioprotective Mechanisms of Glutathione S-transferase P
-
批准号:7788879
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2008
-
负责人:Daniel Joseph Conklin
-
依托单位:
Cardioprotective Mechanisms of Glutathione S-transferase P
-
批准号:8053818
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2008
-
负责人:Daniel Joseph Conklin
-
依托单位:
Cardioprotective Mechanisms of Glutathione S-transferase P
-
批准号:7612771
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2008
-
负责人:Daniel Joseph Conklin
-
依托单位:
Aldehydes and Coronary Artery Vasospasm
-
批准号:6357612
-
项目类别:
-
资助金额:$14.2万
-
财政年份:2002
-
负责人:Daniel Joseph Conklin
-
依托单位:
Core D - Animal Models and Phenotyping Core
-
批准号:8711508
-
项目类别:
-
资助金额:$14.82万
-
财政年份:--
-
负责人:Daniel Joseph Conklin
-
依托单位:
Core B: Tobacco Product Evaluation and Exposure Core
-
批准号:8906925
-
项目类别:
-
资助金额:$56.95万
-
财政年份:--
-
负责人:Daniel Joseph Conklin
-
依托单位:
Core D - Animal Models and Phenotyping Core
-
批准号:9130199
-
项目类别:
-
资助金额:$14.82万
-
财政年份:--
-
负责人:Daniel Joseph Conklin
-
依托单位:
Core B: Tobacco Product Evaluation and Exposure Core
-
批准号:8737961
-
项目类别:
-
资助金额:$56.89万
-
财政年份:--
-
负责人:Daniel Joseph Conklin
-
依托单位:
Core D - Animal Models and Phenotyping Core
-
批准号:9300981
-
项目类别:
-
资助金额:$14.82万
-
财政年份:--
-
负责人:Daniel Joseph Conklin
-
依托单位:
Core D - Animal Models and Phenotyping Core
-
批准号:8601970
-
项目类别:
-
资助金额:$14.82万
-
财政年份:--
-
负责人:Daniel Joseph Conklin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: